DEVICE
Foley balloon
Foley balloon for induction of labor
Status
Active, not recruiting
Phase
Not applicable
Enrollment
100
Locations
1
Results
Not posted
Publications
12
Study summary
A randomized trial of patients undergoing a term (≥37 weeks) induction of labor with a history of one prior Cesarean delivery, wherein the provider intends to use a Foley catheter for cervical ripening. The investigators will be comparing Foley alone with concurrent Foley and Oxytocin use at the start of the induction. With this trial, the investigators aim to test our central hypothesis that concurrent Foley and Oxytocin will decrease time to delivery without increasing risks, compared to Foley alone.
Interventions
DEVICE
Foley balloon for induction of labor
DRUG
Pitocin for induction of labor
Timeline
First posted
Jun 5, 2025
Study start
Jul 10, 2025
Primary completion
Jul 2026
Study completion
May 1, 2027
Results posted
Not reported
Registry updated
Jun 18, 2026
Outcomes
Time to delivery
Time frame · At delivery
The primary endpoint will be time from start of induction until delivery (hours)
Estimated postpartum blood loss
Time frame · At delivery
Estimated postpartum blood loss in mL
Postpartum hemorrhage
Time frame · Within 6 weeks of delivery
Estimated blood loss≥ 1L
Number of Participants with Chorioamnionitis
Time frame · At delivery
Documented chorioamnionitis
Mode of delivery
Time frame · At delivery
Successful vaginal birth after cesarean (VBAC) or repeat cesarean delivery (rCD)
Number of Participants with Uterine Rupture
Time frame · At delivery
Uterine rupture noted at the time of cesarean delivery
Maternal morbidity
Time frame · Within 6 weeks of delivery
Defined as a composite endpoint consisting of at least one occurrence of the following outcomes: postpartum hemorrhage, blood transfusion, endometritis, wound/laceration breakdown or infection, venous thromboembolism and hospital readmission with 6 weeks
Neonatal morbidity
Time frame · Within 6 weeks of delivery
Defined as neonatal resuscitation requiring supplemental oxygen outside of the delivery room for at least 12 hours of culture proven/presumed neonatal sepsis
Maternal length of stay
Time frame · From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery
Measured by hours from admission to postpartum discharge
Neonatal length of stay
Time frame · From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery
Length of stay from birth to discharge, measured in hours
NICU stay greater than 48 hours
Time frame · From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery
Admission to the NICU for more than 48 hours
Eligibility
Inclusion Criteria: * Eligible for induction of labor * Live singleton gestation ≥37 weeks * History of 1 cesarean delivery * ≥18 years of age * Cephalic presentation * Intact membranes * English or Spanish speaking (Able to read/understand consent and instructions) * Cervical dilation \<3cm and Bishop score \<8 Exclusion Criteria: * \>1 prior Cesarean delivery * Known chorioamnionitis * Major fetal anomaly
Study locations
United States. Showing up to 24 locations stored in the fast local snapshot.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Publications
Related trials
Wake Forest University Health Sciences · Total Hip Arthroplasty
Phase 2
Enrolling by invitation
80
2026-07
Yale University · Pain · Pituitary Surgery
Phase 2
Not yet recruiting
75
2026-07
Medical University of South Carolina · PTSD · Alcohol Use Disorder
Phase 2
Completed
175
2026-07
University Hospital, Tours · Cervical Ripening · Unfavorable Cervix
Phase 3
Recruiting
1,494
2026-07
Icahn School of Medicine at Mount Sinai · Pregnancy · Labor
Phase 3
Recruiting
281
2026-07
Elizabeth Austen Lawson · Vasopressin Deficiency
Phase 1
Recruiting
40
2026-07
Massachusetts General Hospital · Arginine Vasopressin Deficiency · Oxytocin Deficiency
Early Phase 1
Recruiting
20
2026-07
Aalto University · Induction of Birth · Cervical Ripening
Not applicable
Recruiting
40
2026-07
Related PeptideStat pages
Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.